Skip to content
PeptideSport
AM Rx logo

Provider review

AM Rx review

Operates under an active FTC/DOJ lawsuit over billing practices, per prior research

AM Rx's own site markup names its navigation container "zealthy-menu-container" — confirmed on this pass — directly matching prior research recording that AM Rx is operated by FitRX, LLC, which also operates Zealthy and FitRx as sibling storefronts. Per that prior research, AM Rx's parent faces an active FTC/DOJ lawsuit alleging deceptive billing and subscription practices, has received two FDA warning letters (September 2025 and February 2026) over misbranding compounded GLP-1s, faces a Novo Nordisk false-advertising lawsuit filed August 2025, and the parent company holds a BBB rating of D- with over 2,370 complaints — none of that independently re-verified on this pass beyond the shared-operator code evidence, and each is a matter of public record worth checking directly rather than taking on faith either way. On price, AM Rx coordinates insurance for brand-name GLP-1s as low as $25/month, alongside compounded semaglutide from $151/month on a quarterly plan.

Verified August 2026

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

AM Rx is a telehealth platform operated by FitRX, LLC — confirmed via a "zealthy-menu-container" class in the site's own markup, matching prior research that FitRX, LLC also operates Zealthy and FitRx as sibling brands. It offers insurance coordination for brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) as low as $25/month, and compounded semaglutide from $151/month on a quarterly plan. Per prior research not independently re-verified on this pass, its parent company faces an active FTC/DOJ lawsuit over deceptive billing and subscription practices, has received two FDA warning letters (September 2025, February 2026) for misbranding compounded GLP-1s, faces a Novo Nordisk false-advertising lawsuit, and holds a BBB rating of D- with more than 2,370 complaints. Anyone considering AM Rx should verify the current status of each of these directly before enrolling.

AM Rx is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

  • You've independently verified the current status of the FTC/DOJ lawsuit and FDA warning letters and are still comfortable enrolling
  • You want insurance coordination for brand-name GLP-1s specifically
  • You want video visits with providers averaging 10+ years of experience

Look elsewhere if

  • You want a provider without active regulatory or legal scrutiny to research first
  • You want a parent company with a strong BBB rating, not a D-
  • You'd rather avoid a storefront that shares infrastructure with sibling brands under the same scrutiny

What it actually costs

What they advertise

Compounded semaglutide "from $151/mo" (quarterly plan); brand-name GLP-1s with insurance coordination "as low as $25/mo," per getamrx.com.

What you actually pay, month to month

The $151/mo figure requires the quarterly plan; the $25/mo brand-name figure depends on individual insurance coverage and is not guaranteed.

Checked live on AM Rx's own site at https://getamrx.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what AM Rx bundles in, and what it does not.

Clinician consult

Video and async consultations are available, per the homepage.

Bloodwork / labs

Not addressed in the sources read.

Follow-ups and dose changes

Not addressed with a specific cadence in the sources read.

Human support

Providers average 10+ years of experience, per the homepage.

Injection supplies

Not itemized in the sources read.

Shipping

Not addressed with specific terms in the sources read.

Pharmacy, labs and oversight

The pharmacy

Not named in the sources read.

Oversight

Video and async consultations are available, per the homepage. Not addressed with a specific cadence in the sources read.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

Not published as a list in the sources read.

The honest cons

The part they would rather you skipped

Per prior research, this provider's parent company faces an active FTC/DOJ lawsuit over billing practices, two FDA warning letters, a Novo Nordisk false-advertising suit, and a D- BBB rating with thousands of complaints — none independently re-verified on this pass beyond the shared-operator evidence found in the site's own code, but each a matter of public record worth checking directly.

  • Parent company faces an active FTC/DOJ lawsuit over billing practices, per prior research not independently re-verified on this pass
  • Two FDA warning letters for misbranding compounded GLP-1s, per prior research
  • Novo Nordisk false-advertising lawsuit, per prior research
  • Parent company BBB rating of D- with 2,370+ complaints, per prior research

None of this is unique to AM Rx — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect AM Rx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on AM Rx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.